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Sir
We read with interest the article by Hadjiloucas et al (2001) on
apoptosis in human breast tissue using an antibody against caspase
3. They recognise that ‘many methods are available for the
measurement of apoptosis but the ‘gold standard’ is to identify
apoptotic cells by their morphological features using microscopy’
Moreover, ‘the TUNEL method fails to distinguish apoptosis from
necrosis, and only detects lat stages of the process, and furthermore
can produce artefactual positive results where nuclei are cut during
the sectioning procedure’.
The authors found, on the other hand, that the use of caspase 3
immunostain is ‘a robust method for assessing in biopsies from
breast epithelia’. For many years we have investigated apoptosis
in colorectal neoplasms, with the TUNEL method, as well as with
immunostains such as p53, CD3, MCHII, TIA1 cell antigens and
Fas methods (Rubio et al, 1996; Rubio, 1997). In colorectal
neoplasms, particularly in adenomas, the results indicated that
the apoptotic nuclear granules (known as Leuchtenberger or Coun-
cilman bodies) derive not from the epithelial cells but from the
intraepithelial lymphocytes which often inﬁltrated the neoplastic
cells. The TUNEL method labelled some apparently well preserved
neoplastic cells. Proliferation studies with an antibody to Ki67
(MIB1) showed that the majority of the neoplastic epithelial cells
were actively synthesising DNA (thus conceivably viable, apparently
not ‘planning’ for an imminent programmed cell death).
On the other hand, CD3, MCHII and TIA1 cell antigens were
positive in intraepithelial lymphocytes (IELs) from adenomas, inci-
pient carcinomas and overt adenocarcinomas (Rubio et al, 1999).
In the normal colorectal mucosa and in metaplastic polyps, CD3
was positive but MCHII and TIA1 were not expressed. Whereas
the Fas cell antigen was expressed in the normal mucosa and in
metaplastic polyps, it was downregulated in neoplastic lesions.
The upregulation of CD3, MCH class II molecules, and TIA1 in
IELs of neoplastic colorectal lesions suggested that those lympho-
cytes were activated and cytotoxic. However, their Fas ligand was
unable to induce apoptosis on epithelial neoplastic cells because
the Fas molecule of neoplastic cells was downregulated. In contrast,
the Fas ligand of the neoplastic cells was able to induce the apop-
tosis of IELs because the Fas molecule of IELs remained intact. A
similar phenomenon seems to take place in experimentally-induced
colonic neoplasias in rats (Rubio, 1998). Thus, the possibility that
lymphocytes may have contributed to the bulk of apoptotic gran-
ules in breast tumours (alas! also inﬁltrated by lymphocytes)
cannot be disregarded. Leuchtenberger or Councilman bodies are
just bodies; they do not disclose if they are of epithelial or of
lymphatic origin. In this respect, it may be of interest to mention
that Liang et al (2001) recently found that human breast MCF-7
cancer cells do not express caspase 3.
Interestingly, Hadjiloucas et al (2001) concluded that ‘the
appearance of the active form of caspase 3 in the cytoplasm of
the cells undergoing apoptosis is an early event and precedes the
development of the classical morphological features of apoptosis’.
A similar argument was used many years ago upon the launch-
ing of the TUNEL method.
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